[1]陈伦,祁佳,张宇锋,等.香砂六君子汤治疗糖尿病性胃轻瘫临床疗效对比研究[J].西部中医药,2016,29(07):90-93.
　CHEN Lun,QI Jia,ZHANG Yufeng,et al.Curative Effects of XiangSha LiuJunZi Tang in Treating Diabetic Gastroparesis[J].Western Journal of Traditional Chinese Medicine,2016,29(07):90-93.
点击复制

香砂六君子汤治疗糖尿病性胃轻瘫临床疗效对比研究

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
29
期数:
2016年07期
页码:
90-93
栏目:
出版日期:
2016-07-15

文章信息/Info

Title:
Curative Effects of XiangSha LiuJunZi Tang in Treating Diabetic Gastroparesis
文章编号:
1004-6852(2016)07-0090-04
作者:
陈伦1，祁佳1，张宇锋2，范涛2△
1 上海交通大学医学院附属新华医院，上海 200092； 2 南京中医药大学附属江阴市中医院
Author(s):
CHEN Lun1, QI Jia1, ZHANG Yufeng2, FAN Tao2△
1 Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;2 Jiangyin TCM Hospital Affiliated to Nanjing University of TCM
关键词:
胃轻瘫; 糖尿病性; 香砂六君子汤; 莫沙必利
Keywords:
gastroparesis;  diabetic;  XiangSha LiuJunZi Tang;  mosapride
分类号:
R587.1
文献标志码:
B
摘要:
目的:比较香砂六君子汤与莫沙必利治疗糖尿病性胃轻瘫的临床疗效。方法:将糖尿病性胃轻瘫患者156例随机分为2组各78例，香砂六君子汤组予香砂六君子汤治疗，莫沙必利组予莫沙必利治疗，2周为1个疗程，2个疗程后观察疗效。结果:总有效率香砂六君子汤组为74.4%，莫沙必利组为80.8%，2组比较差异无统计学意义(P＞0.05)；2组患者胃排空时间均较治疗前缩短，差异有统计学意义(P＜0.05)；2组治疗后胃排空时间比较差异无统计学意义(P＞0.05)；治疗组副反应发生率低于对照组，但差异无统计学意义(P＞0.05)。结论:香砂六君子汤治疗糖尿病性胃轻瘫，有一定临床疗效，能改善患者胃排空时间，与莫沙必利比较在临床疗效、胃排空时间方面无显著差异。
Abstract:
Objective: To compare clinical effects between XiangSha LiuJunZi Tang and mosapride in treating diabetic gastroparesis (DG). Methods: All 156 patients were randomized into two groups, 78 cases each group, XiangSha LiuJunZi Tang group accepted XiangSha LiuJunZi Tang, mosapride group received mosapride, two weeks were one course of the treatment, and clinical effects of both groups were observed after two courses of the treatment. Results: Total effective rate of the treatment group was 74.4%, lower than 80.8% of the control group, and the difference had no statistical meaning (P＞0.05). Gastric emptying time of both groups shortened obviously, the difference had statistical meaning (P＜0.05); and it showed no statistical meaning in the comparison between both groups after treating (P＞0.05). The treatment group was lower than the control group in the incidence of adverse reaction, but the difference presented no statistical meaning (P＞0.05). Conclusion: XiangSha LiuJunZi Tang could obtain the definite effects in treating DG, and it could improve gastric emptying time of the patients. There is no significant difference in the comparison of clinical effects and gastric emptying time between XiangSha LiuJunZi Tang and mosapride.

相似文献/References:

[1]王开放,张建中△.古代治疗糖尿病胃轻瘫组方的用药规律分析[J].西部中医药,2018,31(12):35.
　WANG Kaifang,ZHANG Jianzhong.Analysis of the Medication Rules of Ancient Prescriptions in Treating Diabetic Gastroparesis[J].Western Journal of Traditional Chinese Medicine,2018,31(07):35.
[2]马欢欢,王晓晖,王晶,等.基于“肾藏精生髓主骨”理论探讨中医药介导miRNA干预糖尿病性骨质疏松症研究进展[J].西部中医药,2025,38(08):105.[doi:10.12174/j.issn.2096-9600.2025.08.19]
　MA Huanhuan,WANG Xiaohui,WANG Jing,et al.Research Progress of TCM-mediated miRNA Intervention for Diabetic Osteoporosis Based on the Theory of "Kidney Storing Essence, Producing Marrow and Governing Bone"[J].Western Journal of Traditional Chinese Medicine,2025,38(07):105.[doi:10.12174/j.issn.2096-9600.2025.08.19]
[3]陈远方,张智,余卫锋,等.电针治疗糖尿病胃轻瘫的Meta分析[J].西部中医药,2021,34(03):77.[doi:10.12174/j.issn.2096-9600.2021.03.20]
　CHEN Yuanfang,ZHANG Zhi,YU Weifeng,et al.Meta Analysis of Acusector in the Treatment for Diabetic Gastroparesis[J].Western Journal of Traditional Chinese Medicine,2021,34(07):77.[doi:10.12174/j.issn.2096-9600.2021.03.20]
[4]刘应东,王翼洲.健脾益气消导方治疗糖尿病胃轻瘫的临床研究[J].西部中医药,2012,25(10):5.
　LIU Ying-dong,WANG Yi-zhou.Clinical Study on JianPi YiQi XiaoDaoFang in Treating Diabetic Gastroparesis[J].Western Journal of Traditional Chinese Medicine,2012,25(07):5.

备注/Memo

备注/Memo:
收稿日期：2015-10-21 *基金项目：国家自然科学基金(编号81302768)。 作者简介：陈伦(1981—)，男，硕士学位，主管药师。研究方向：中、西药药动学新方法及其关键技术研究。 △通讯作者：范涛(1971—)，男，副主任医师。研究方向：中药现代。
更新日期/Last Update: 2016-07-15